Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Thyroid Gland Neoplasm”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Not applicableUnknownNCT04560426
What this trial is testing

Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation

Who this might be right for
ParathyroidIntraoperative MonitoringThyroid Cancer
Fudan University 200
Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Not applicableEnrolling By InvitationNCT05836246
What this trial is testing

The Development of Quantitative Ultrasound Imaging Software Platform

Who this might be right for
Chronic Liver DiseaseThyroid DiseaseBenign Breast Disease+2 more
Seoul National University Bundang Hospital 196
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableEnded earlyNCT05003856
What this trial is testing

Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule

Who this might be right for
Benign Thyroid Gland NeoplasmRecurrent Thyroid Gland CarcinomaThyroid Gland Follicular Tumor of Uncertain Malignant Potential+2 more
M.D. Anderson Cancer Center 1
Post-approval studies (Phase 4)UnknownNCT00902122
What this trial is testing

RAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Who this might be right for
Advanced Malignant Thyroid Tumors
Shenzhen SiBiono GeneTech Co.,Ltd 600
Not applicableStudy completedNCT06405919
What this trial is testing

Risk of Malignancy in Endemic Long Standing Nodular Goitres: a Prospective Cohort Study

Who this might be right for
Incidence of Thyroid Cancer in Long Standing MNG
University of Khartoum 160
Not applicableStudy completedNCT02592356
What this trial is testing

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Adrenal Gland PheochromocytomaMalignant Paraganglioma+1 more
M.D. Anderson Cancer Center 23
Not applicableUnknownNCT00929318
What this trial is testing

Influence of Thyroid Hormones on the Woundhealing Process

Who this might be right for
Thyroid NeoplasmsThyroid Carcinoma
Hannover Medical School 26
Early research (Phase 1)Looking for participantsNCT07181720
What this trial is testing

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Lung CancerAnaplastic Thyroid Carcinomas+3 more
Chongqing Precision Biotech Co., Ltd 90
Not applicableUnknownNCT04842994
What this trial is testing

Trial on Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery.

Who this might be right for
Malignant Neoplasm of Thyroid Gland
Tata Memorial Hospital 448
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Not applicableLooking for participantsNCT05088187
What this trial is testing

Cognition and QoL After Thyroid Surgery

Who this might be right for
Thyroid NoduleThyroid CancerCognitive Decline+2 more
Karolinska University Hospital 320
Not applicableStudy completedNCT06258044
What this trial is testing

The Application Value of Deep Learning-Based Nomograms in Benign-Malignant Discrimination of TI-RADS Category 4 Thyroid Nodules

Who this might be right for
Thyroid Nodule
Ma Zhe 500
Not applicableStudy completedNCT01089335
What this trial is testing

Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia

Who this might be right for
Thyroid NeoplasmsThyroid Cancer
Region Skane 100
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Not applicableUnknownNCT03772496
What this trial is testing

Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells)

Who this might be right for
Thyroid NoduleDiagnoses Disease
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284774
What this trial is testing

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Malignant Solid NeoplasmRecurrent Adrenal Gland PheochromocytomaRecurrent Ectomesenchymoma+38 more
National Cancer Institute (NCI) 5
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Load More Results